CPRX - カタリスト・ファ―マシュ―ティカルズ (Catalyst Pharmaceuticals Inc.)

CPRXのニュース

   Catalyst Pharma +3.4% as director buys 20,000 shares  2018-12-14
Catalyst Pharmaceuticals (NASDAQ: CPRX ) is up 3.4% postmarket, after the disclosure that director Charles O'Keeffe bought 20,000 shares today. More news on: Catalyst Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more …

calendar